Skip to content
December 23, 2022

Melanoma Immunotherapy with GPR182 blockade

Description: Immune checkpoint inhibitor therapy has greatly improved survival of patients with late-stage melanoma. However, about 2/3 of patients do not benefit from this...

2 Minute Read

Mar 01, 2026 ET - Mar 03, 2026

2026 Advocacy Days

Mar 28, 2026 ET

Jam for Cam

Mar 28, 2026 ET

Hope in Bloom Ball

Apr 06, 2026 ET

Together Against Melanoma: UNC Lineberger Comprehensive Cancer Center Patient & Caregiver Symposium

Apr 17, 2026 ET - Apr 19, 2026

2026 Eyes on a Cure: Ocular Melanoma Patient & Caregiver Symposium

May 08, 2026 CT

Stay Out of the Sun Run

May 09, 2026 ET

DC Miles for Melanoma 5K

Explore Events